Clinical Study of Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of Extensive Stage Small Cell Lung Cancer
Latest Information Update: 31 Jan 2024
At a glance
- Drugs Camrelizumab (Primary) ; Carboplatin (Primary) ; Etoposide (Primary) ; Rivoceranib (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions
- 06 Jun 2023 Results presented at the 59th Annual Meeting of the American Society of Clinical Oncology.
- 23 Aug 2021 New trial record